Robustness Predictive Factors in People Aged Over 75 Years After Going to the Emergency Room (ROB-U) (ROB-U)

Study of the Robustness Predictive Factors in People Aged Over 75 Years After Going to the Emergency Room

After emergency room visits, the elderly patients can increase their dependence and functional decline. In this context the goal of this study is to demonstrate that there are robustness predictive factors after visit to the emergency room.

Study Overview

• Status: Completed
• Conditions: Aging; Risk Factors; Emergency Room

Detailed Description

The emergency department is one of the main access routes to the hospital for elderly patients.

Older age is often associated with an increase risk of longer stay in the emergency room with a high subsequent risk of hospital re-admission. One of the essential care objectives when treating these patients is to maintain the autonomy to avoid any dependence in order to keep the quality of life, and limit the time of hospitalization.

Emergency room visits and hospitalizations are too often considered as a source of autonomy loss aggravation in the elderly. Many studies have demonstrated the mortality predictive factors existence, functional decline, or re-hospitalization of the elderly after an emergency room visit or after hospitalization.

No study until now has investigated the existence of factors directly predictive of robustness. Then the goal of this study is to demonstrate that there are robustness predictive factors after going to the emergency room.

• Study Type: Observational
• Enrollment (Actual): 110

Contacts and Locations

Study Locations

• France
  • Haut-de-France
    • Lille, Haut-de-France, France, 59000
      • Saint-Vincent Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 75 years and older (Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

The study population is composed of patients aged more than 75 years old and who have eligibility criteria.

Description

Inclusion Criteria:

• Patients admitted to the emergency room
• Patients aged ≥ 75 years old
• Patients without cognitive disorders or vigilance disorders
• Patients living at home
• Patients able to give its non-opposition

Non inclusion Criteria:

• Patients admitted to the hospital in the last 3 months
• Patients refusing to participate in the study

Exclusion Criteria:

• Patients whose stay is < 14h or > 48h
• Patients who die during hospitalization
• Patient not hospitalized
• Patient not returning home after discharge from hospital

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Identification of predictive factors of robustness : Autonomy level at home (ADL score)	ADL self-performance coding ranges from 0 (independent) to 4 (total dependence).	3 months
Identification of predictive factors of robustness by a questionnaire (help at home)	Need of help at home such as : toilet, breakfast, lunch, dinner (yes or not)	3 months
Identification of predictive factors of robustness by a questionnaire (family visits)	Number of family visits	3 months
Identification of predictive factors of robustness by a questionnaire (appetit)	loss of appetite (yes or not)	3 months
Identification of predictive factors of robustness (heart rate)	Heart rate during hospitalization (minimum and maximum values)	3 months
Identification of predictive factors of robustness (Modified Triage Risk Screening Tool (TRST)) score	The TRST score is a tool to predict repeat emergency department visits and hospitalizations in older patients discharged from the emergency department; This tool evaluates 5 dimensions : cognitive disorders presence, walking disorders, polymedication, hospitalization antecedents and functional assessment (loss of autonomy). Every dimension is worth 1 point if the patient presents the disorder. The final maximum score is 5 points.	3 months
Identification of predictive factors of robustness : BMI (Body Mass Index)	Body mass index	3 months
Albuminemia	Rate of Albuminemia	3 months
Identification of predictive factors of robustness : Lifestyle	Lifestyle: person living alone (yes or not)	3 months
Sleep assessment using a Visual Analog Scale (VAS).	This scale allows patients to assess their fatigue. The patients locate their fatigue intensity on a 100-millimeters horizontal line. Using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity.	3 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Rate of re-hospitalization	Only direct re-hospitalizations in emergency rooms and geriatric short stay will be counted	3 months
Rate of patient survival	Rate of patient survival	3 months
Rate of lack of Institutionalization	Rate of lack of Institutionalization	3 months

Collaborators and Investigators

• Sponsor: Lille Catholic University
• Investigators: Principal Investigator: Jean Bouquillon, Hôpital Saint-Vincent de Paul

Study record dates

Study Major Dates

• Study Start (Actual): March 10, 2021
• Primary Completion (Actual): December 10, 2021
• Study Completion (Actual): December 10, 2021

Study Registration Dates

• First Submitted: December 16, 2020
• First Submitted That Met QC Criteria: December 21, 2020
• First Posted (Actual): December 24, 2020

Study Record Updates

• Last Update Posted (Actual): January 6, 2022
• Last Update Submitted That Met QC Criteria: January 5, 2022
• Last Verified: January 1, 2022

More Information

Terms related to this study

• Keywords: Emergency room visits; Elderly dependence; Lack of autonomy; Robustness; Re-hospitalization
• Additional Relevant MeSH Terms: Pathologic Processes; Disease Attributes; Emergencies
• Other Study ID Numbers: RC-P0099

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No